How CoQun entered a stagnant glaucoma neuroprotection market in Ukraine by building medical context, field expertise, and a memorable scientific symbol.
How CoQun entered a stagnant glaucoma neuroprotection market in Ukraine by building medical context, field expertise, and a memorable scientific symbol.
Sona Group announces the start of its cooperation with VitaVitro, strengthening its international network and expanding pharmaceutical collaboration.
Sona Group announces the start of its cooperation with Coripharma, strengthening its international network and expanding pharmaceutical collaboration across Europe.
Sona-Exim explores how pharma marketing is shifting toward scientific value, multidisciplinary education, and integrated HCP engagement.
From Dialogue to Development: Sona Group participated in a broader multi-stakeholder initiative aimed at expanding access to assisted reproductive technologies in Uzbekistan.
Sona-Exim reached #3 position in the Ukrainian ophthalmology market in April 2026, demonstrating 19% sales growth and strong market performance in a declining category.
For over 20 years, Sona Group has worked in reproductive medicine, helping make innovative treatment solutions accessible to patients across different countries.
Sona Group team joined the European Business Association session on intercultural meetings to explore how global teams build clearer, stronger communication across cultures.
Sona-Exim shares how AI inside CRM helps reduce routine work, support planning and improve execution across pharma markets.
Sona Group announces the start of its cooperation with Pharmacare Srl, strengthening its international network and expanding pharmaceutical collaboration across Europe.
APRaD and Sona-Pharm emphasize HTA transparency, pricing policy, and strategic healthcare reforms as essential for access to innovative medicines in Ukraine
Insights from the Ophthalmic Synergy masterclass in Kyiv on multidisciplinary ophthalmology, dry eye disease, and broader clinical decision-making.